ARDT

Ardent Health
ARDT

Upgrade to unlock
Buy
Hold
Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13.44
56% upside
High target

9 analyst ratings

positive
2  neutral
22%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
A.J. Rice
0% 1-yr ARDT win rate
18 Dec ‘25 1 month ago
Mizuho
Mizuho
Ann Hynes
33% 1-yr ARDT win rate
18 Dec ‘25 1 month ago
JP Morgan
JP Morgan
Benjamin Rossi
24 Nov ‘25 1 month ago
Guggenheim
Guggenheim
Jason Cassorla
67% 1-yr ARDT win rate
18 Nov ‘25 2 months ago
Keybanc
Keybanc
Matthew Gillmor
0% 1-yr ARDT win rate
17 Nov ‘25 2 months ago
RBC Capital
RBC Capital
Ben Hendrix
0% 1-yr ARDT win rate
14 Nov ‘25 2 months ago
Truist Securities
Truist Securities
David Macdonald
0% 1-yr ARDT win rate
14 Nov ‘25 2 months ago
Stephens & Co
Stephens & Co
Scott Fidel
50% 1-yr ARDT win rate
14 Nov ‘25 2 months ago
Morgan Stanley
Morgan Stanley
Craig Hettenbach
0% 1-yr ARDT win rate
14 Nov ‘25 2 months ago
BofA Securities
BofA Securities
Kevin Fischbeck
50% 1-yr ARDT win rate
13 Nov ‘25 2 months ago